Search PubMed⌕ Search

PubMed · 2144127

[The informed consent].

Abstract

To what extent can or should a patient influence medical decisions? For a valid decision to be made, it is usually considered essential that the patient be autonomous and competent. If a person is not incapacitated for autonomous action, he can accept or reject a medical intervention on the basis of the information available to him. This raises the question of what the patient is to be told. The answer rests on which value is considered fundamental in medical practice: the patient's well-being or respect for his status as a person. This controversy arises in both the strictly therapeutic and the research contexts. In both cases, information must be explicit and clear. Many printed forms are hard to understand; the patient's signature merely precludes the possibility of legal problems. Depending on the kind of disease and treatment, the patient's consent may at times be almost tacit while at other times it should be based on complete information, especially if his decision seems irrational or contrary to the physician's judgment. In clinical trials, information and consent problems usually relate to the possibility that information given the participant will invalidate the findings. Nevertheless, the patient's rights and well-being should always be considered more important than the research.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M C Lara, J R de la Fuente. [The informed consent].. https://pubmed.ncbi.nlm.nih.gov/2144127/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

The concept of risk in biomedical research involving human subjects.

An established ethical principle of biomedical research involving human subjects stipulates that risk to subjects should be proportionate to an experiment's potential benefits. Sometimes this principle is imprecisely stated as a requirement that 'risks and benefits' be balanced. First, it is noted why this language is imprecise. Second, the persistence of such language is attributed to how it functions as a rhetorical trope. Finally, an argument is made that such a trope is infelicitous because it may not achieve its intended persuasive purposes. More importantly, it should be avoided because it masks the important role that chance plays in clinical research. Risk is the possibility of harm. As a precondition of harm it is unintended and undesirable in projects of biomedical research. It requires ethical vigilance. As a vehicle of chance, however, it is both intended and desirable. It requires methodological appreciation.

Human Experimentation↗

Human experimentation in Judaism.

The supreme value of human life, the sanctity of human life, and the obligation of patients to accept standard efficacious medical therapy are axiomatic Judaic principles. If a seriously and/or terminally ill patient has already received all standard treatments and is asked to consider experimental therapy that may prolong his or her life or may hasten death, he or she is allowed but not required to accept the treatment. Healthy people may volunteer to participate in research studies that involve little or no risk.

Human Experimentation↗